140 related articles for article (PubMed ID: 18852277)
1. Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice.
Chacon-Moreno BE; Welsh O; Cavazos-Rocha N; de la Luz Salazar-Cavazos M; Garza-Lozano HG; Said-Fernandez S; Ocampo-Candiani J; Vera-Cabrera L
Antimicrob Agents Chemother; 2009 Jan; 53(1):295-7. PubMed ID: 18852277
[TBL] [Abstract][Full Text] [Related]
2. In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.
Piercy T; Steward J; Lever MS; Brooks TJ
J Antimicrob Chemother; 2005 Dec; 56(6):1069-73. PubMed ID: 16223941
[TBL] [Abstract][Full Text] [Related]
3. Construction of a Nocardia brasiliensis fluorescent plasmid to study Actinomycetoma pathogenicity.
Salinas-Carmona MC; Rocha-Pizaña MR
Plasmid; 2011 Jan; 65(1):25-31. PubMed ID: 20875450
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Activity of the Benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis.
González-Martínez NA; Lozano-Garza HG; Castro-Garza J; De Osio-Cortez A; Vargas-Villarreal J; Cavazos-Rocha N; Ocampo-Candiani J; Makarov V; Cole ST; Vera-Cabrera L
PLoS Negl Trop Dis; 2015; 9(10):e0004022. PubMed ID: 26474057
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Combined Therapy of DA-7218, a New Oxazolidinone, and Trimethoprim/ Sulfamethoxazole in the Treatment of Experimental Actinomycetoma by Nocardia brasiliensis.
Espinoza-Gonzalez NA; Welsh O; Ocampo-Candiani J; Said-Fernandez S; Lozano-Garza G; Choi SH; Vera-Cabrera L
Curr Drug Deliv; 2010 Jul; 7(3):225-9. PubMed ID: 20497102
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis.
Espinoza-González NA; Welsh O; de Torres NW; Cavazos-Rocha N; Ocampo-Candiani J; Said-Fernandez S; Lozano-Garza G; Choi SH; Vera-Cabrera L
Molecules; 2008 Jan; 13(1):31-40. PubMed ID: 18259127
[TBL] [Abstract][Full Text] [Related]
7. Systemic increased immune response to Nocardia brasiliensis co-exists with local immunosuppressive microenvironment.
Salinas-Carmona MC; Rosas-Taraco AG; Welsh O
Antonie Van Leeuwenhoek; 2012 Oct; 102(3):473-80. PubMed ID: 22825801
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase blockade with aminoguanidine, protects mice infected with Nocardia brasiliensis from actinomycetoma development.
Salinas-Carmona MC; Longoria-Lozano O; Garza-Esquivel HR; López-Ulloa J; Reyes-Carrillo J; Vázquez-Marmolejo AV
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008775. PubMed ID: 33091049
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
López-Merino A; Contreras-Rodríguez A; Migranas-Ortiz R; Orrantia-Gradín R; Hernández-Oliva GM; Gutiérrez-Rubio AT; Cardeñosa O
Scand J Infect Dis; 2004; 36(9):636-8. PubMed ID: 15370648
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effect of diethylcarbamazine in mice infected with Nocardia brasiliensis.
García-Hernández M; Castro-Corona MA; Segoviano-Ramírez JC; Brattig NW; Medina-De la Garza CE
Int Immunopharmacol; 2014 Nov; 23(1):113-20. PubMed ID: 25150175
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
Oliveira AD; D'Azevedo PA; Francisco W
Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
[TBL] [Abstract][Full Text] [Related]
12. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
Alkorta M; Giménez MJ; Vicente D; Aguilar L; Pérez-Trallero E
Int J Antimicrob Agents; 2005 Feb; 25(2):163-7. PubMed ID: 15664487
[TBL] [Abstract][Full Text] [Related]
13. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.
Vallet CM; Marquez B; Ngabirano E; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
Int J Antimicrob Agents; 2011 Sep; 38(3):249-56. PubMed ID: 21764262
[TBL] [Abstract][Full Text] [Related]
14. IgM but not IgG monoclonal anti-Nocardia brasiliensis antibodies confer protection against experimental actinomycetoma in BALB/c mice.
Gonzalez-Suarez ML; Salinas-Carmona MC; Pérez-Rivera I
FEMS Immunol Med Microbiol; 2009 Oct; 57(1):17-24. PubMed ID: 19624737
[TBL] [Abstract][Full Text] [Related]
15. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium.
Sano C; Tatano Y; Shimizu T; Yamabe S; Sato K; Tomioka H
Int J Antimicrob Agents; 2011 Apr; 37(4):296-301. PubMed ID: 21353489
[TBL] [Abstract][Full Text] [Related]
17. A novel experimental immunomodulatory therapy against Nocardia brasiliensis in a BALB/c murine model.
García-Lozano JA; García-Berlanga CC; Viveros-Rosado RT; Ocampo-Candiani J; Vargas-Villarreal J; Vera-Cabrera L
Clin Exp Dermatol; 2020 Jul; 45(5):544-548. PubMed ID: 31729068
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis.
Vera-Cabrera L; Daw-Garza A; Said-Fernández S; Lozano-Garza HG; de Torres NW; Rocha NC; Ocampo-Candiani J; Choi SH; Welsh O
PLoS Negl Trop Dis; 2008 Sep; 2(9):e289. PubMed ID: 18820738
[TBL] [Abstract][Full Text] [Related]
19. Nocardia brasiliensis: mycetoma induction and growth cycle.
Conde C; Melendro EI; Fresán M; Ortiz-Ortiz L
Infect Immun; 1982 Dec; 38(3):1291-5. PubMed ID: 7152671
[TBL] [Abstract][Full Text] [Related]
20. Nocardia brasiliensis cell wall lipids modulate macrophage and dendritic responses that favor development of experimental actinomycetoma in BALB/c mice.
Trevino-Villarreal JH; Vera-Cabrera L; Valero-Guillén PL; Salinas-Carmona MC
Infect Immun; 2012 Oct; 80(10):3587-601. PubMed ID: 22851755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
